(MENAFN- America News Hour)
Research Nester published a report titled “Subarachnoid Hemorrhage Surgical Devices Market : Global Demand Analysis & Opportunity Outlook 2030” which delivers detailed overview of the global subarachnoid hemorrhage surgical devices market in terms of market segmentation by device type, surgery type, end-user, and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
The global subarachnoid hemorrhage surgical devices market is estimated to gain a significant CAGR over the forecast period, i.e., 2022–2030. The market is segmented by end-user into hospitals, ambulatory surgical centers, and others, out of which the ambulatory surgical centers segment is anticipated to grow significantly throughout the forecast period owing to the focused and more effective treatment facilities provided in ASCs, along with lesser expenses compared to hospitals.
The global subarachnoid hemorrhage surgical devices market is estimated to grow on the back of rising prevalence of SAH and growing R&D investment for medical research. Subarachnoid hemorrhage or SAH is caused due to the rupture of a swelled vein inside the brain, where the blood clots between the brain and the skull. Various factors, such as, family history and poor lifestyle, along with excessive alcohol abuse can be responsible for SAH. Surgery is the only treatment for this condition, which is estimated to drive the growth of the market. Moreover, favorable reimbursement and health insurance policies, increasing R&D activities, and rising investment in the healthcare sector are estimated to further boost the market growth.
Request Sample For More Information @
On the basis of region, the global subarachnoid hemorrhage surgical devices market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America region is estimated to hold largest market share over the forecast period owing to the region's high healthcare expenditure and R&D investment, combined with the presence of major market players, and availability of advanced health equipment and technology in the region. Moreover, higher per capita healthcare expenditure in countries, such as, the US, and Canada, is estimated to contribute towards the market growth in the forecast period.
Growing Cases of SAH and Increasing Need for Surgery to drive the Market Growth
According to the data by the American Heart Association, incidence of subarachnoid hemorrhage (SAH) is estimated to be 6 to 8 per 100,000 person every year, globally.
SAH is a rare but very deadly condition, which is increasing due to excessive consumption of tobacco, alcohol, cocaine, and other drugs. The increasing incidences of SAH has increased the need for surgical devices, as surgery is the only treatment to cure the subarachnoid hemorrhage. This is estimated to significantly boost the market growth.
However, high cost of treatment and complications associated with the surgery are expected to operate as key restraint to the growth of the market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global subarachnoid hemorrhage surgical devices market which includes company profiling of Medtronic plc, Stryker Corporation, Abbott Laboratories, General Electric Company, Terumo Corporation, Becton, Dickinson and Company, Cardinal Health, Inc., Penumbra, Inc., Baxter International, Inc., and Koninklijke Philips N.V. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global subarachnoid hemorrhage surgical devices market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Grab PDF Sample For More Information @
Explore Similar Press Releases from Same Source:
Dental Diagnostic & Surgical Equipment Market
Gel Warmers Market
Phototherapy Equipment Market
Vitreoretinal Surgery Devices Market
Anti-Malarial Drugs Market
About Research Nester:
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.
Contact for more Info:
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
Research Nester is a one-stop service provider, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives to make wise decisions for their future investment and expansion by providing them qualitative market insights and strategies while avoiding future uncertainties. We believe in honesty and sheer hard work that we trust is reflected in our work ethics. Our vision is not just limited to gain the trust of our clients but also to be equally respected by our employees and being appreciated by the competitors.
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.